Adaptogens have a marketing problem. The word has been so thoroughly colonised by wellness branding that a supplement with a substantial peer-reviewed evidence base gets lumped in with whatever extract somebody has discovered will photograph well on Instagram. Ashwagandha deserves better than that. The clinical evidence — particularly for KSM-66 and Sensoril, the two patented root extracts with the most robust trial data — is genuinely strong, and the mechanism is specific enough to be clinically useful rather than vaguely wellness-adjacent.
The starting point is not stress. The starting point is the HPA axis and what chronic HPA activation does to the hormonal and metabolic picture over time.
What chronic HPA dysregulation actually produces
The hypothalamic-pituitary-adrenal axis is the body's primary stress response system. Under chronic activation — which in clinical practice means sustained life stress, physical overtraining, sleep insufficiency, inflammatory load, or blood sugar instability — it produces a predictable downstream pattern. Cortisol rises. DHEA-S falls. The ratio between them shifts toward catabolism — the body breaking down faster than it rebuilds. Testosterone, progesterone, and thyroid T3 conversion are all suppressed downstream of this shift. The DUTCH hormone panel makes this pattern visible across the diurnal curve.
The evidence — what the trials actually show
KSM-66 versus Sensoril — the form matters
Both are patented ashwagandha root extracts with published clinical trials. They are not interchangeable and the difference is worth understanding.
| Characteristic | KSM-66 | Sensoril |
|---|---|---|
| Part of plant | Root only | Root and leaf |
| Withanolide content | ≥5% | ≥10% (more concentrated) |
| Typical dose | 300–600mg daily | 125–250mg daily |
| Primary evidence base | Cortisol, testosterone, thyroid, fertility, athletic performance | Cortisol, anxiety, sleep, cognitive function |
| Best clinical fit | HPA recovery with testosterone/thyroid support priority | Anxiety, sleep, cognitive stress response priority |
| Timing | Morning, with food | Can split morning/evening or evening alone for sleep |
Unpatented ashwagandha supplements vary significantly in withanolide content and bioavailability. The trials that produced the evidence base used KSM-66 or Sensoril. Using an unspecified "ashwagandha root extract" at unclear withanolide content and expecting trial-equivalent results is optimistic at best.
When testing confirms the indication
Ashwagandha is most clinically indicated when DUTCH data shows the HPA dysregulation pattern — elevated or dysregulated cortisol, suppressed DHEA-S, downstream hormone impairment — in the context of a clinical history of chronic stress, overtraining, or sustained inflammatory load. It is not a supplement for subclinical anxiety without an identified HPA axis component, and it is not a replacement for addressing the upstream drivers of cortisol dysregulation.
"If the DUTCH shows the pattern, ashwagandha is one of the few supplements where the indication is confirmed by data rather than assumed from symptoms — and where a repeat DUTCH at 12 weeks can demonstrate the effect objectively."
Cautions and contraindications
Ashwagandha is a Solanaceae (nightshade) family plant. Individuals with nightshade sensitivity should approach cautiously. Thyroid-stimulating effect means caution is warranted in hyperthyroidism or Graves' disease — the evidence for thyroid support is in hypothyroid and subclinical contexts, not in already-elevated thyroid function states. Pregnancy: avoid. Autoimmune conditions where immune stimulation could be problematic — monitor carefully. Sedative medications: potential additive effect on sleep.
Is your HPA axis driving your symptoms?
The DUTCH Plus hormone panel maps your full cortisol diurnal curve, DHEA-S, and downstream sex hormones — confirming whether the HPA dysregulation pattern is present before any protocol is designed around it.
See the TDG Programme →